scispace - formally typeset
Journal ArticleDOI

Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells

Reads0
Chats0
TLDR
The synthesis and anti-tumoral properties of a series of compounds possessing a ferrocenyl group tethered to a catechol via a conjugated system is presented and the probable involvement of such oxidative metabolites in the in vitro activity of these species is demonstrated.
Abstract
The synthesis and anti-tumoral properties of a series of compounds possessing a ferrocenyl group tethered to a catechol via a conjugated system is presented. On MDA-MB-231 breast cancer cell lines, the catechol compounds display a similar or greater anti-proliferative potency (IC50 values ranging from 0.48–1.21 μM) than their corresponding phenolic analogues (0.57–12.7 μM), with the highest activity found for species incorporating the [3]ferrocenophane motif. On the electrochemical timescale, phenolic compounds appear to oxidize to the quinone methide, while catechol moieties form the o-quinone by a similar mechanism. Chemical oxidation of selected compounds with Ag2O confirms this interpretation and demonstrates the probable involvement of such oxidative metabolites in the in vitro activity of these species.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Exploration of the medical periodic table: towards new targets

TL;DR: Progress in identifying and defining target sites has been accelerated recently by advances in proteomics, genomics and metal speciation analysis, and examples of metal compounds and chelating agents (enzyme inhibitors) currently in clinical use, clinical trials or preclinical development are highlighted.
Journal ArticleDOI

Recent advances in iron complexes as potential anticancer agents

TL;DR: The aspects of the photocytotoxicity, redox activity and multinuclearity of anticancer iron complexes are discussed, in addition to discussing ferrocenyl derivatives and salen complexes.
Journal ArticleDOI

Oxidation‐Responsive Polymers: Which Groups to Use, How to Make Them, What to Expect From Them (Biomedical Applications)

TL;DR: A review of chemical groups that can respond to physiologically occurring oxidants can be found in this paper, where an overview of the preparative processes of polymers containing groups such as metallocenes, (poly) pyridyl metal complexes, polyconjugated sequences, thiols, thioethers (sulfi des), and stannanes is reviewed.
Journal ArticleDOI

Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.

TL;DR: This review will provide an overview of ferrocene-containing hybrids with potential application in the treatment of cancers covering articles published between 2010 and 2020.
Journal ArticleDOI

Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies

TL;DR: The role of structure-reactivity relationships in enhancing the anticancer potential of drugs for the benefit of humans both in vitro and in vivo is discussed.
References
More filters
Journal ArticleDOI

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

TL;DR: Tamoxifen significantly reduced the rate of treatment failure at local and distant sites, tumors in the opposite breast, and the incidence of tumor recurrence after lumpectomy and breast irradiation and was attained with a low incidence of clinically appreciable toxic effects.
Journal ArticleDOI

Tamoxifen in the Treatment of Breast Cancer

TL;DR: Tamoxifen was approved by the Food and Drug Administration in 1977 for the treatment of women with advanced breast cancer and several years later for adjuvant treatment of primary breast cancer.
Journal ArticleDOI

Treatment of breast cancer

TL;DR: Management of breast cancer was last reviewed in the Journal in 1992 and the accumulation of new biologic information, the results of recent clinical trials, and the availability of new diagnostic and therapeutic tools make it appropriate to review the subject again.
Related Papers (5)